IRTC News and Press, iRhythm Technologies Inc. From 12/15/23

2023-12-15 01:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

SAN FRANCISCO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the results of a new retrospective analysis, conducted in partnership with Duke Health, that found incorporating ECG data from long-term continuous monitoring can more accurately predict hear...

2023-11-02 23:30:20 ET iRhythm Technologies, Inc. (IRTC) Q3 2023 Earnings Conference Call November 02, 2023 04:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President & Chief Executive Officer Brice Bo...

2023-11-02 16:11:43 ET More on iRhythm Technologies iRhythm: Implied Expectations Appear Warranted, High Risk Priced In At Current Multiples iRhythm Technologies Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on iRhythm Technologies Historical e...

SAN FRANCISCO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three and nine months ended September ...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

iRhythm Technologies Inc. (IRTC) is expected to report $-0.65 for Q3 2023

SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2023 a...

2023-10-13 14:00:58 ET Summary iRhythm Technologies' investment prospects have dampened in 2023 due to regulatory issues and a lack of economic catalysts. The company received a warning letter from the FDA regarding non-conformities to regulations for its Zio AT System back in May...

iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S. Zio ® monitor builds on the high performance of Zio ® XT that, together with its enhanced Zio ® long term continuous cardiac monitoring service, provides an elevated end-...